Free shipping on all orders over $ 500

Teduglutide

Cat. No. M10249
Teduglutide Structure
Synonym:

ALX 0600; Gattex; Revestive; TAK 633

Size Price Availability Quantity
1mg USD 108  USD108 In stock
5mg USD 216  USD216 In stock
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control & Documentation
Biological Activity

Teduglutide is a glucagon-like peptide-2 (GLP-2) analogue used for the treatment of short-bowel syndrome. Teduglutide has similar binding affinity, agonist potency, and agonist efficacy as GLP-2 in assays with the rat GLP-2 receptor. Administration of teduglutide to rats gave a significant increase in small intestine weight and an increase in the height of intestinal villi.

Product Citations
Chemical Information
Molecular Weight 3752.08
Formula C164H252N44O55S
CAS Number 197922-42-2
Solubility (25°C) DMSO 30 mg/mL
Storage -20°C, sealed, protect from light
Conversion of different model animals based on BSA (PMID: 27057123)
Species Mouse Rat Rabbit Guinea pig Hamster Dog
Weight (kg) 0.02 0.15 1.8 0.4 0.08 10
Body Surface Area (m2) 0.007 0.025 0.15 0.05 0.02 0.5
Km factor 3 6 12 8 5 20
Animal A (mg/kg) = Animal B (mg/kg) multiplied by  Animal B Km
Animal A Km

For example, to modify the dose of Compound A used for a mouse (20 mg/kg) to a dose based on the BSA for a rat, multiply 20 mg/kg by the Km factor for a mouse and then divide by the Km factor for a rat. This calculation results in a rat equivalent dose for Compound A of 10 mg/kg.

References

[1] Beatrice E Rosete, et al. Expert Rev Gastroenterol Hepatol. Teduglutide for pediatric short bowel syndrome patients

[2] No authors listed. Aust Prescr. Teduglutide for short bowel syndrome

[3] Samuel A Kocoshis, et al. JPEN J Parenter Enteral Nutr. Safety and Efficacy of Teduglutide in Pediatric Patients With Intestinal Failure due to Short Bowel Syndrome: A 24-Week, Phase III Study

[4] Palle B Jeppesen, et al. Gastroenterology. Factors Associated With Response to Teduglutide in Patients With Short-Bowel Syndrome and Intestinal Failure

[5] Palle B Jeppesen, et al. Gastroenterology. Teduglutide reduces need for parenteral support among patients with short bowel syndrome with intestinal failure

Related GLP Receptor Products
Amycretin

Amycretin is a novel, potentially first-in-class, long-acting co-agonist of GLP-1 and the amyloid receptor (AMYR) for obesity-related studies.

NM-003

NM-003 is a GLP-2R agonist that can be used in studies related to inflammatory bowel disease.

NB-1002

NB-1002 is a GLP-2R agonist that can be used in studies related to short bowel syndrome.

MOD-15014

MOD-15014 is a GLP-2R modulator that can be used in studies related to short bowel syndrome.

HM-15912

HM-15912 is a GLP-2R agonist that can be used in studies related to short bowel syndrome.

  Catalog
Abmole Inhibitor Catalog




Keywords: Teduglutide, ALX 0600; Gattex; Revestive; TAK 633 supplier, GLP Receptor, inhibitors, activators


Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.